VEA
ABMD

Virtus ETF Advisers’s Abiomed Inc ABMD Stock Holding History

Virtus ETF Advisers’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,383
Closed -$590K – 474
2022
Q2 		$590K Buy
+2,383
New +$643K 0.22% 202
2020
Q3 		– Sell
-61
Closed -$15K – 440
2020
Q2 		$15K Sell
61
-22
-27% -$4.42K 0.01% 407
2020
Q1 		$12K Buy
83
+27
+48% +$4.48K ﹤0.01% 380
2019
Q4 		$10K Buy
+56
New +$10.4K ﹤0.01% 434

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Virtus ETF Advisers's ABMD Position: Q3 2022 in Review

Virtus ETF Advisers sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 2,383 shares — an estimated $590K sold.

Virtus ETF Advisers first reported a position in ABMD in Q4 2019 and held it in 4 quarters. The position peaked at $590K in Q2 2022. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Virtus ETF Advisers reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 2,383 Abiomed Inc shares in Q3 2022, an estimated $590K.
  • Virtus ETF Advisers first reported a position in Abiomed Inc in Q4 2019 and held it in 4 quarters.
  • Virtus ETF Advisers's Abiomed Inc position peaked at $590K in Q2 2022.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Virtus ETF Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.